ACI's Advanced Forum on Biotech Patents

WHEN

  • September 30 8:00 AM - October 1, 2009 4:15 PM

WHERE

  • Royal Sonesta Hotel
  • 40 Edwin Land Boulevard
  • Cambridge, MA 02142
  • Map

DESCRIPTION

Foley Hoag's Barbara Fiacco to speak at this conference.

For more details, please access ACI's website.

Come to the one forum that will help you revise your strategies to adapt to new industry standards.

Emerging from a turbulent year of new case law, a resurgence of the proposed PTO rules, uncertainty associated with a new administration, and tough economic conditions, biotech patent practitioners must prepare for a new phase in this ever-evolving field. And with groundbreaking legislation regarding patent reform and follow-on biologics on the horizon, patent counsel must rise to the challenge to overcome increasing rejections, promote innovation and maximize profitability.

With this in mind, ACI’s 11th Advanced Forum on Biotech Patents once again brings together a high-caliber team of experienced biotech patent counsel who will share their collective knowledge and provide you with the most up to date strategies you can immediately incorporate into your practice.

Dedicated to the unique challenges faced by the biotech industry, your expert faculty will uncover critical insights involving:

  • Developing a practical approach to follow-on biologics
  • Preparing for the rule changes rising out of the Tafas decision
  • Strategically avoiding rejection in diagnostic, method of treatment, and method of screening claims
  • Delving into techniques to defeat charges of inequitable conduct
  • Insights into key rule changes in foreign patent offices, including a special presentation on the EPO and EU patent litigation
  • Overcoming challenges to antibody patent prosecution

Add value to your experience by attending our highly successful, interactive and in-depth Master Class on Drafting Successful Patent Applications for Biotechnology Inventions where you will learn how to master the art of drafting complex patent applications for your biotech inventions.